Neprilysin Inhibitors as a New Approach in the Treatment of Right Heart Failure in the Course of Chronic Obstructive Pulmonary Disease. Response to the Letter of Siniorakis et al.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.